InspireMD, Inc. (NSPR) vs TELA Bio, Inc. (TELA)

InspireMD, Inc. and TELA Bio, Inc. are both Medical Devices companies. TELA Bio, Inc. is the larger, with a market value of $35.2M against $29.7M — 1.2× the size. InspireMD, Inc. grew revenue faster over the last twelve months: 53.4% against 6.09%. TELA Bio, Inc. has the higher net margin (−51.5% vs −484.1%) and the higher return on invested capital (−217.1% vs −3,071.0%). Across the 17 metrics below, TELA Bio, Inc. leads on 15 and InspireMD, Inc. on 2.

Valuation

Metric NSPR TELA Medical Devices median
P/E n/m n/m 25.58
P/S 4.92 0.60 2.54
P/B 1.69 n/m 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 2.46 0.97 2.72
Earnings yield (101.59%) (91.67%) (12.82%)
Free cash flow yield (79.58%) (71.78%) (8.18%)

Profitability

Metric NSPR TELA Medical Devices median
Gross margin 18.05% 68.29% 57.76%
Operating margin (494.03%) (42.56%) (15.07%)
Net margin (484.11%) (51.53%) (14.45%)
Free cash flow margin (391.53%) (39.57%) (3.88%)
Return on equity (202.81%) 1,232.54% (10.35%)
Return on assets (134.60%) (64.71%) (17.26%)
Return on invested capital (3,070.99%) (217.11%) (5.27%)

Growth

Metric NSPR TELA Medical Devices median
Revenue growth (TTM) 53.42% 6.09% 10.41%
EPS growth (last fiscal year) 0.00% 37.59% 28.17%
Revenue growth, 5-year CAGR 29.29% 34.54% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NSPR TELA Medical Devices median
Debt to equity 0.00 (3.53) 0.04
Current ratio 3.80 2.99 2.74
Net debt to EBITDA 1.10 (0.15) 0.54

Dividend

Metric NSPR TELA Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric NSPR TELA Medical Devices median
Market cap 29.71m 35.21m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack